Find out about the Latest in Advancements for Esophageal Cancer Treatment
ECAN will host a free webinar on Tuesday, March 4, 2025 at 2:15 pm Eastern time to explore the [...]
ECAN will host a free webinar on Tuesday, March 4, 2025 at 2:15 pm Eastern time to explore the [...]
The Food and Drug Administration (FDA) has approved Zolbetuximab (Vyloy) as a first-line treatment for patients with advanced HER2* [...]
A German study finds a 30% reduction in the risk of death among Esophageal Adenocarcinoma patients who were treated [...]
In 2021, Esophageal Cancer patients and advocates celebrated the Food and Drug Administration’s approval of immunotherapies for patients with [...]
This day is meant to honor those special men who have made a significant difference in our lives. Now, [...]
DEADLINE FAST APPROACHING! Join ECAN on Capitol Hill in June as we advocate to end Esophageal Cancer with our [...]
Millions are available for research into the prevention, detection, diagnosis, treatment, and survival of Esophageal Cancer through the Department [...]
ECAN started Esophageal Cancer Awareness Month 15 years ago and we have been delighted to see how many companies, [...]
March 27, 2024 marks 16 years since my extraordinary husband Monte Mordecai took his last breath on earth. I’m [...]
A newly released study of the benefits of the EsoGuard® Esophageal DNA test says it is a powerful screening [...]